Claims for Patent: 6,361,998

Summary for Patent: 6,361,998

Title:	Efficient culture of stem cells for the production of hemoglobin
Abstract:	The present invention describes a serum-free medium that promotes the growth and differentiation of erythroid cells, cells that are highly transducible by a non-viral method and genes which increase the growth of erythroid cells and decrease their dependency on Epo. This invention can be used in the expansion of hematopoietic stem cells to produce cultures of erythroid cells as a source of erythroid-specific proteins such as hemoglobin. Hematopoietic stem cells are cultured ex vivo in a serum-free culture medium with the addition of IL-3, SCF and EPO. Cells transfected with the gene described in the present invention can be cultured in the serum-free culture medium with decreased dependency on Epo and other cytokines, thereby reducing the cost of the production of hemoglobin.
Inventor(s):	Bell; David N. (Oakville, CA), Matthews; Kathryn Emma (Toronto, CA), Mueller; Susan G. (Milton, CA)
Assignee:	Hemosol Inc. (Mississauga, CA)
Application Number:	09/339,838
Patent Claims:	1. A method of producing an expanded population of erythroid cells comprising culturing an initial population containing erythroid precursors in a serum free defined medium essentially free of fatty acids and hydrocortisone comprising effective amounts of: serum albumin, insulin, transferrin, IL-3, SCF, SA and Epo and recovering an expanded population of erythroid cells. 2. A method of producing a differentiated population of erythroid cells comprising culturing an initial population containing erythroid precursors in a serum free defined medium essentially free of fatty acids and hydrocortisone comprising effective amounts of: serum albumin, insulin, transferrin, IL-3, SCF, SA and Epo and recovering a differentiated population of erythroid cells. 3. A method of enhancing the expansion and differentiation of a population of erythroid cells comprising: (a) culturing an initial population comprising erythroid precursors in a suitable erythroid cell culture medium in the presence of SA, and (b) adding an effective amount of a heme source. 4. The method of claim 3 wherein the heme source is hemin. 5. The method of claim 3 wherein the heme source is Hb. 6. The method of claim 3 wherein the erythroid cell culture medium is EPSFM+LDL. 7. The method of claim 3 wherein the erythroid cells are derived from a human. 8. A method of producing exogenous protein in erythroid cells comprising: (a) culturing an initial cell population in a serum free defined culture medium comprising effective amounts of serum albumin, insulin, transferrin, IL-3, SCF, Epo, SA and LDLs, (b) electroporating cells in the presence of exogenous DNA, encoding said protein (c) allowing cells to recover in an appropriate post-electroporation medium, (d) screening the electroporated cells for exogenous protein expression, (e) culturing cells of step (d) which express exogenous protein and (f) recovering the protein from the cells of step (e). 9. The method of claim 8 wherein the foreign source protein is a globin protein. 10. The method of claim 8 wherein the foreign source protein is a transcription factor. 11. The method of claim 8 wherein the foreign source protein is an immortalizing protein. 12. The method of claim 8 wherein the foreign source protein is a genetically altered growth factor receptor. 13. A human EpoR having an R.fwdarw.C mutation at amino acid residue 154 and truncated at amino acid residue 439 and having the amino acid sequence shown in SEQ. ID. NO.7. 14. An erythroid cell expressing the EpoR of claim 13. 15. A method of enhancing the expansion of a population of erythroid cells comprising culturing an initial population comprising erythroid precursors in a suitable erythroid cell culture medium in the presence of SA.

Details for Patent 6,361,998

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	PANHEMATIN	hemin for injection	For Injection	101246	07/20/1983		2040-01-28